Skip to Main Content

Paper Details

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing <i>DPYD</i> and <i>UGT1A1</i> Screening to Guide Chemotherapy Dosing.
Front Oncol
3
2022
5-FU, Fluoropyrimidines, GI malignancy, Gastrointestinal Cancers, NCT04736472, PGx, capecitabine, fluorouracil, gastrointestinal (GI) malignancies, germline, irinotecan, patient, patients
Author NameAffiliation
Margaret HarrCenter for Applied Genomics, The Children's Hospital of Philadelphia
Hakon HakonarsonCenter for Applied Genomics, The Children's Hospital of Philadelphia
Hakon HakonarsonCenter for Applied Genomics, The Children's Hospital of Philadelphia
Sony TutejaPerelman School of Medicine, University of Pennsylvania
  • 1 - 4

Datasets

Release 1.2